Transfusion and Apheresis Science
Volume 35, Issue 1 , Pages 5-17, August 2006

The Mirasol™ PRT system for pathogen reduction of platelets and plasma: An overview of current status and future trends

  • Raymond P. Goodrich

      Affiliations

    • Navigant Biotechnologies, Inc., 1215 Quail Street, Lakewood, CO 80215, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 303 250 2680; fax: +1 303 239 2389.
  • ,
  • Richard A. Edrich

      Affiliations

    • Navigant Biotechnologies, Inc., 1215 Quail Street, Lakewood, CO 80215, United States
  • ,
  • Junzhi Li

      Affiliations

    • Navigant Biotechnologies, Inc., 1215 Quail Street, Lakewood, CO 80215, United States
  • ,
  • Jerard Seghatchian

      Affiliations

    • Blood Components Technology and Haemostasis/Thrombosis Consultancy, 50 Primrose Hill Road, London NW3 3AA, United Kingdom

Received 6 January 2006; accepted 9 January 2006.

Abstract 

The safety of blood transfusion is still threatened by contamination of blood products with a variety of pathogens such as viruses, bacteria and parasites. A novel pathogen reduction process for platelets and plasma products, the Mirasol PRT system, has been developed and is under clinical evaluation for its efficacy and safety. The Mirasol PRT process is based on riboflavin photochemistry. This manuscript reviews current progress and future trends.

Keywords: Riboflavin, Pathogen inactivation, Blood safety, Transfusion medicine

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1473-0502(06)00085-1

doi:10.1016/j.transci.2006.01.007

Transfusion and Apheresis Science
Volume 35, Issue 1 , Pages 5-17, August 2006